ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy.

Youngran Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.